A phase II trial of capecitabine and vinorelbine as first-line treatment in patients with metastatic breast cancer (BC)

被引：0
|
作者：
Palumbo, Raffaella [1 ]
Bernardo, Antonio [1 ]
Strada, Maria Rosa [1 ]
Poggi, Guido [1 ]
Delmonte, Angelo [1 ]
Teragni, Cristina [1 ]
Frascaroli, Mara [1 ]
Bernardo, Giovanni [1 ]
机构：
[1] Fdn Maugeri, Pavia, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：75 / 75
页数：1
相关论文
共 50 条
  • [41] Multicenter Phase II Study of Pegylated Liposomal Doxorubicin in Combination with Vinorelbine as First-Line Treatment in Elderly Patients with Metastatic Breast Cancer
    Mlineritsch, Brigitte
    Schabel-Moser, Renate
    Andel, Johannes
    Fridrik, Michael
    Moik, Martin
    Mayer, Peter
    Russ, Gudrun
    Rass, Christof
    Greil, Richard
    ONKOLOGIE, 2009, 32 (1-2): : 18 - 24
  • [42] A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer
    Subramanyan, S
    Abeloff, MD
    Bond, SE
    Davidson, NE
    Fetting, JH
    Gordon, GB
    Kennedy, MJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (06) : 497 - 502
  • [43] A clinical phase II study of cisplatin and vinorelbine followed by docetaxel as first-line treatment in metastatic breast cancer (MBC).
    Yassine, H
    Khalifeh, M
    Bitar, N
    Charafeddine, M
    Dheiny, M
    Chehal, A
    Jalloul, R
    Dandashi, A
    Wehbeh, M
    Shamseddine, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 83S - 83S
  • [44] A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer
    Smitha Subramanyan
    Martin D. Abeloff
    Stephen E. Bond
    Nancy E. Davidson
    John H. Fetting
    Gary B. Gordon
    M. John Kennedy
    Cancer Chemotherapy and Pharmacology, 1999, 43 : 497 - 502
  • [45] Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients (pts) with HER2-positive metastatic breast cancer (MBC)
    Peacock, N. W.
    Infante, J. R.
    Yardley, D. A.
    Burris, H. A., III
    Greco, F. A.
    Farley, C.
    Webb, C.
    Spigel, D. R.
    Hainsworth, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [46] Triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer (MBC): latest results of an international phase II trial
    Chan, A.
    Ganju, V.
    Becquart, D.
    Conte, P. F.
    Petruzelka, L.
    Perrot, O.
    Villanova, G.
    Tubiana-Mathieu, N.
    EJC SUPPLEMENTS, 2007, 5 (04): : 221 - 222
  • [47] Phase II study of bevacizumab in combination with capecitabine as first-line treatment in elderly patients with metastatic colorectal cancer
    Vrdoljak, Eduard
    Omrcen, Tomislav
    Boban, Marijo
    Hrabar, Andina
    ANTI-CANCER DRUGS, 2011, 22 (02) : 191 - 197
  • [48] A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines
    Orphanos, George
    Alexopoulos, Athanasios
    Malliou, Savvoula
    Ioannidis, George
    Ardavanis, Alexandros
    Kandylis, Constantinos
    Stavrakakis, John
    Rigatos, Gerassimos
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (01) : 115 - 121
  • [49] Gemcitabine plus vinorelbine as first-line treatment of metastatic breast cancer.
    Gokmen, E
    Sezgin, C
    Karabulut, B
    Vazquez, A
    Sanal, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 85S - 85S
  • [50] All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial
    Tubiana-Mathieu, N.
    Bougnoux, P.
    Becquart, D.
    Chan, A.
    Conte, P-F
    Majois, F.
    Espie, M.
    Morand, M.
    Vaissiere, N.
    Villanova, G.
    BRITISH JOURNAL OF CANCER, 2009, 101 (02) : 232 - 237
12345